The Journal of Immunology, Vol 156, Issue 12 4680-4685, Copyright © 1996 by American Association of Immunologists

ARTICLES

Characterization of molecular interactions between intercellular adhesion molecule-1 and leukocyte function- associated antigen-1

JR Woska Jr, MM Morelock, DD Jeanfavre and BJ Bormann
Section of Cell Adhesion in Department of Immunologic Diseases, Boehringer Ingelheim Pharmaceuticals, Research and Development Center, Ridgefield, CT 06877, USA.

The ability of soluble ICAM-1 (sICAM-1) to inhibit ICAM-1/LFA-1 adhesion events has been reported previously by numerous investigators. sICAM-1 has been demonstrated to inhibit various in vitro assays at concentrations ranging from 2 nM to greater than 40 microM. Given the hypothesis that circulating ICAM-1 modulates immune functions, the ability of sICAM-1 to inhibit cellular functions may have significant ramifications. Considering the potential clinical importance of the interaction between ICAM-1 and its receptor, LFA-1, it is necessary to understand this receptor-ligand interaction at a molecular level. In this study, direct binding experiments were utilized to determine the affinity between biotinylated monomeric sICAM-1 and immobilized LFA-1 (approximately 130 nM). Competitive binding experiments with unlabeled sICAM-1 and a truncated form of sICAM-1 (D1D2) yielded similar affinities. The specificity of this interaction was characterized using mAbs directed against sICAM-1 or LFA-1. This assay system was extended to include multimeric species using nonblocking mAbs directed against domains D4 and D5 of sICAM-1. Dimerizing sICAM-1 with a mAb alphaD4 or alphaD5 increased the affinity for immobilized LFA-1 by two orders of magnitude (approximately 4 nM), an effect presumably due to avidity. These results indicate that while the monomeric sICAM-1/LFA-1 interaction may involve only a moderate binding affinity, multimeric ICAM-1 present on a cell surface may bind cell surface-immobilized LFA- 1 with very high avidity. These sICAM-1/LFA-1 molecular assays should be useful in defining the efficacy of potential antagonists.

This article has been cited by other articles:

				M. R. Sarantos, S. Raychaudhuri, A. F. H. Lum, D. E. Staunton, and S. I. Simon Leukocyte Function-associated Antigen 1-mediated Adhesion Stability Is Dynamically Regulated through Affinity and Valency during Bond Formation with Intercellular Adhesion Molecule-1 J. Biol. Chem., August 5, 2005; 280(31): 28290 - 28298. [Abstract] [Full Text] [PDF]

				D. Ehirchiou, Y.-M. Xiong, Y. Li, S. Brew, and L. Zhang Dual Function for a Unique Site within the {beta}2I Domain of Integrin {alpha}M{beta}2 J. Biol. Chem., March 4, 2005; 280(9): 8324 - 8331. [Abstract] [Full Text] [PDF]

				L. Fraemohs, R. R. Koenen, G. Ostermann, B. Heinemann, and C. Weber The Functional Interaction of the {beta}2 Integrin Lymphocyte Function-Associated Antigen-1 with Junctional Adhesion Molecule-A Is Mediated by the I Domain J. Immunol., November 15, 2004; 173(10): 6259 - 6264. [Abstract] [Full Text] [PDF]

				E. B. Lomakina and R. E. Waugh Micromechanical Tests of Adhesion Dynamics between Neutrophils and Immobilized ICAM-1 Biophys. J., February 1, 2004; 86(2): 1223 - 1233. [Abstract] [Full Text] [PDF]

				N. Hogg, M. Laschinger, K. Giles, and A. McDowall T-cell integrins: more than just sticking points J. Cell Sci., December 1, 2003; 116(23): 4695 - 4705. [Abstract] [Full Text] [PDF]

				E. P. Wojcikiewicz, X. Zhang, A. Chen, and V. T. Moy Contributions of molecular binding events and cellular compliance to the modulation of leukocyte adhesion J. Cell Sci., June 15, 2003; 116(12): 2531 - 2539. [Abstract] [Full Text] [PDF]

				X. Zhang, E. Wojcikiewicz, and V. T. Moy Force Spectroscopy of the Leukocyte Function-Associated Antigen-1/Intercellular Adhesion Molecule-1 Interaction Biophys. J., October 1, 2002; 83(4): 2270 - 2279. [Abstract] [Full Text] [PDF]

				M. L. Lupher Jr., E. A. S. Harris, C. R. Beals, L. Sui, R. C. Liddington, and D. E. Staunton Cellular Activation of Leukocyte Function-Associated Antigen-1 and Its Affinity Are Regulated at the I Domain Allosteric Site J. Immunol., August 1, 2001; 167(3): 1431 - 1439. [Abstract] [Full Text] [PDF]

				C.-D. Jun, M. Shimaoka, C. V. Carman, J. Takagi, and T. A. Springer Dimerization and the effectiveness of ICAM-1 in mediating LFA-1-dependent adhesion PNAS, June 5, 2001; 98(12): 6830 - 6835. [Abstract] [Full Text] [PDF]

				T. A. Kelly, D. D. Jeanfavre, D. W. McNeil, J. R. Woska Jr., P. L. Reilly, E. A. Mainolfi, K. M. Kishimoto, G. H. Nabozny, R. Zinter, B.-J. Bormann, et al. Cutting Edge: A Small Molecule Antagonist of LFA-1-Mediated Cell Adhesion J. Immunol., November 15, 1999; 163(10): 5173 - 5177. [Abstract] [Full Text] [PDF]

				Y. van Kooyk, S. J. van Vliet, and C. G. Figdor The Actin Cytoskeleton Regulates LFA-1 Ligand Binding through Avidity Rather than Affinity Changes J. Biol. Chem., September 17, 1999; 274(38): 26869 - 26877. [Abstract] [Full Text] [PDF]

				Y. Tominaga, Y. Kita, A. Satoh, S. Asai, K. Kato, K. Ishikawa, T. Horiuchi, and T. Takashi Affinity and Kinetic Analysis of the Molecular Interaction of ICAM-1 and Leukocyte Function-Associated Antigen-1 J. Immunol., October 15, 1998; 161(8): 4016 - 4022. [Abstract] [Full Text] [PDF]

				K. Kusterer, J. Bojunga, M. Enghofer, E. Heidenthal, K. H. Usadel, H. Kolb, and S. Martin Soluble ICAM-1 reduces leukocyte adhesion to vascular endothelium in ischemia-reperfusion injury in mice Am J Physiol Gastrointest Liver Physiol, August 1, 1998; 275(2): G377 - G380. [Abstract] [Full Text] [PDF]

				M. E. Labadia, D. D. Jeanfavre, G. O. Caviness, and M. M. Morelock Molecular Regulation of the Interaction Between Leukocyte Function-Associated Antigen-1 and Soluble ICAM-1 by Divalent Metal Cations J. Immunol., July 15, 1998; 161(2): 836 - 842. [Abstract] [Full Text] [PDF]

				J. R. Woska Jr., M. M. Morelock, D. D. Jeanfavre, G. O. Caviness, B.-J. Bormann, and R. Rothlein Molecular Comparison of Soluble Intercellular Adhesion Molecule (sICAM)-1 and sICAM-3 Binding to Lymphocyte Function-associated Antigen-1 J. Biol. Chem., February 20, 1998; 273(8): 4725 - 4733. [Abstract] [Full Text] [PDF]

				D. A. Calderwood, D. S. Tuckwell, J. Eble, K. Kuhn, and M. J. Humphries The Integrin alpha 1 A-domain Is a Ligand Binding Site for Collagens and Laminin J. Biol. Chem., May 9, 1997; 272(19): 12311 - 12317. [Abstract] [Full Text] [PDF]

				M. Shimaoka, C. Lu, R. T. Palframan, U. H. von Andrian, A. McCormack, J. Takagi, and T. A. Springer Reversibly locking a protein fold in an active conformation with a disulfide bond: Integrin alpha L I domains with high affinity and antagonist activity in vivo PNAS, May 22, 2001; 98(11): 6009 - 6014. [Abstract] [Full Text] [PDF]